Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource

[1]  I. Hickie,et al.  Psychological morbidity in women at increased risk of developing breast cancer: A controlled study , 2005, Psycho-oncology.

[2]  Norman Boyd,et al.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.

[3]  G. Chenevix-Trench,et al.  No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer , 2004, Breast Cancer Research.

[4]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[5]  P. Butow,et al.  Short- and Long-Term Impact of Receiving Genetic Mutation Results in Women at Increased Risk for Hereditary Breast Cancer , 2004, Journal of Genetic Counseling.

[6]  G. Chenevix-Trench,et al.  Germ‐line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen‐responsive proteins and the predominance of progesterone receptor A , 2004, Genes, chromosomes & cancer.

[7]  P. Butow,et al.  Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. , 2003, Journal of women's health.

[8]  H. Thorne,et al.  Clinical, pathological and genetic features of women at high familial risk of breast cancer undergoing prophylactic mastectomy , 2003, Clinical genetics.

[9]  M. Southey,et al.  A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1 , 2003, Human mutation.

[10]  L. V. van't Veer,et al.  Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. , 2003, Cancer research.

[11]  Douglas F. Easton,et al.  Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics , 2003, Human Genetics.

[12]  Nazneen Rahman,et al.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.

[13]  J. Sambrook,et al.  Dominant negative ATM mutations in breast cancer families. , 2002, Journal of the National Cancer Institute.

[14]  S. Seal,et al.  Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  B. Modan,et al.  A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[16]  J. Sambrook,et al.  The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia , 2001, Breast Cancer Research.

[17]  P. Oefner,et al.  Denaturing high‐performance liquid chromatography: A review , 2001, Human mutation.

[18]  P. Butow,et al.  Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer. , 2000, Journal of psychosomatic research.

[19]  R. Osborne,et al.  kConFab: a research resource of Australasian breast cancer families , 2000, The Medical journal of Australia.

[20]  G. Giles,et al.  Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). , 1999, Journal of the National Cancer Institute. Monographs.

[21]  J. Struewing,et al.  Population-based study of risk of breast cancer in carriers of BRCA2 mutation , 1998, The Lancet.

[22]  M. Stratton,et al.  Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.

[23]  L. Le Marchand,et al.  A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[24]  E. Finkel.  Australia Takes Two-Step Approach on Genetic Studies , 1998, Science.

[25]  G. Giles,et al.  Breast cancer in Australian women under the age of 40 , 1998, Cancer Causes & Control.

[26]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[27]  Julian Peto,et al.  Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.

[28]  Steven E. Bayer,et al.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.

[29]  The Polish Breast Cancer Consortium.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002 .